OMB approves the
revised Federal Drug Testing Custody and Control Form (CCF). In
addition, the previous version of the CCF (the CCF with the four
new analytes - oxycodone, oxymorphone, hydrocodone, and
hydromorphone - listed in Step 5A) is authorized for use until
August 30, 2021.
Inventory as of this Action
Requested
Previously Approved
08/31/2023
36 Months From Approved
08/31/2020
26,906,503
0
21,600,061
1,688,948
0
1,350,283
0
0
0
The Federal Drug Testing Custody and
Control Form is used for the Mandatory Guidelines required to in
the chain of custody procedures to document the integrity and
security of a urine specimen from the time it is collected until it
is received by the laboratory.
To ensure uniformity among all
federally regulated workplace drug testing programs, the UrMG and
OFMG require using an OMB-approved Federal CCF (Federal CCF -
Attachment F). To facilitate ease of use and uniform reporting, the
UrMG and OFMG will use a combined format to streamline the Federal
CCF. The combined form will collect all information required by
both Mandatory Guidelines and minimize duplication and cost to the
users.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.